These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 16247189

  • 21. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N, Foderà D, D'Alessandro N, Cusimano A, Azzolina A, Tripodo C, Florena AM, Minervini MI, Notarbartolo M, Montalto G, Cervello M.
    Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
    [Abstract] [Full Text] [Related]

  • 22. Regulation of ANP secretion from isolated atria by prostaglandins and cyclooxygenase-2.
    Bai G, Gao S, Shah A, Yuan K, Park WH, Kim SH.
    Peptides; 2009 Sep; 30(9):1720-8. PubMed ID: 19539681
    [Abstract] [Full Text] [Related]

  • 23. Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H. pylori and NSAID.
    Wu CY, Wu MS, Chen YJ, Chen CJ, Lin JT, Chen GH.
    Hepatogastroenterology; 2006 Sep; 53(71):797-803. PubMed ID: 17086892
    [Abstract] [Full Text] [Related]

  • 24. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.
    Sinicrope FA.
    Mol Carcinog; 2006 Jun; 45(6):447-54. PubMed ID: 16688727
    [Abstract] [Full Text] [Related]

  • 25. Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer.
    Ling FC, Baldus SE, Khochfar J, Xi H, Neiss S, Brabender J, Metzger R, Drebber U, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.
    Histopathology; 2007 Jan; 50(2):203-9. PubMed ID: 17222248
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Expression of Lewis antigens and their precursors in gastric mucosa: relationship with Helicobacter pylori infection and gastric carcinogenesis.
    Lee HS, Choe G, Kim WH, Kim HH, Song J, Park KU.
    J Pathol; 2006 May; 209(1):88-94. PubMed ID: 16456898
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD, Zeng ZR, Hu PJ.
    Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
    [Abstract] [Full Text] [Related]

  • 33. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
    Radi ZA, Khan NK.
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
    [Abstract] [Full Text] [Related]

  • 34. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines.
    Brunelle M, Sartin EA, Wolfe LG, Sirois J, Doré M.
    Vet Pathol; 2006 Sep; 43(5):656-66. PubMed ID: 16966442
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation.
    Colleselli D, Bijuklic K, Mosheimer BA, Kähler CM.
    Exp Cell Res; 2006 Sep 10; 312(15):2933-41. PubMed ID: 16893539
    [Abstract] [Full Text] [Related]

  • 36. Alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells.
    Broom OJ, Massoumi R, Sjölander A.
    J Cell Physiol; 2006 Dec 10; 209(3):950-8. PubMed ID: 16972245
    [Abstract] [Full Text] [Related]

  • 37. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M, Treiber G, Wex T, Kuester D, Roessner A, Di Mario F, Malfertheiner P.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1225-33. PubMed ID: 16611284
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cyclooxygenase-2 as a target for anticancer drug development.
    Méric JB, Rottey S, Olaussen K, Soria JC, Khayat D, Rixe O, Spano JP.
    Crit Rev Oncol Hematol; 2006 Jul 15; 59(1):51-64. PubMed ID: 16531064
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.